Literature DB >> 6378230

Lack of effect of ibopamine, a dopamine pro-drug, on renal function in normal subjects.

J N Harvey, D P Worth, J Brown, M R Lee.   

Abstract

The effects of two single oral doses of ibopamine (150 and 600 mg) on heart rate, blood pressure, urine flow, sodium, potassium and creatinine excretion were studied in normal volunteers. No significant change was observed in urine flow, sodium, potassium or creatinine excretion at either dose. No significant change was observed in heart rate or blood pressure except that systolic blood pressure was transiently elevated after the 600 mg dose (P less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378230      PMCID: PMC1463432          DOI: 10.1111/j.1365-2125.1984.tb02402.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

Review 1.  Characteristics of the vascular dopamine receptor: comparison with other receptors.

Authors:  L I Goldberg; J D Kohli; A N Kotake; P H Volkman
Journal:  Fed Proc       Date:  1978-08

Review 2.  A comparison of the vascular dopamine receptor with other dopamine receptors.

Authors:  L I Goldberg; P H Volkman; J D Kohli
Journal:  Annu Rev Pharmacol Toxicol       Date:  1978       Impact factor: 13.820

Review 3.  Cardiovascular and renal actions of dopamine: potential clinical applications.

Authors:  L I Goldberg
Journal:  Pharmacol Rev       Date:  1972-03       Impact factor: 25.468

4.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

5.  An investigation of the structural requirements for dopamine-like renal vasodilation: phenylethylamines and apomorphine.

Authors:  L I Goldberg; P F Sonneville; J L McNay
Journal:  J Pharmacol Exp Ther       Date:  1968-09       Impact factor: 4.030

6.  Failure of renal dopamine response to salt loading in chronic renal disease.

Authors:  I F Casson; M R Lee; A M Brownjohn; F M Parsons; A M Davison; E J Will; A D Clayden
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-12

7.  Propylbutyldopamine: hemodynamic effects in conscious dogs, normal human volunteers and patients with heart failure.

Authors:  W H Fennell; A A Taylor; J B Young; T A Brandon; J Z Ginos; L I Goldberg; J R Mitchell
Journal:  Circulation       Date:  1983-04       Impact factor: 29.690

8.  Hemodynamic effects of ibopamine in patients with idiopathic congestive cardiomyopathy.

Authors:  L Dei Cas; R Bolognesi; F Cucchini; A Fappani; S Riva; O Visioli
Journal:  J Cardiovasc Pharmacol       Date:  1983 Mar-Apr       Impact factor: 3.105

9.  Ibopamine (SB 7505) in normal subjects and in chronic renal failure: a preliminary report.

Authors:  S Stefoni; L Colì; G Mosconi; R Prandini
Journal:  Br J Clin Pharmacol       Date:  1981-01       Impact factor: 4.335

10.  Failure of salt to mobilise renal dopamine in essential hypertension.

Authors:  C M Perkins; I F Casson; G F Cope; M R Lee
Journal:  Lancet       Date:  1980 Dec 20-27       Impact factor: 79.321

View more
  2 in total

Review 1.  Ibopamine. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.

Authors:  J M Henwood; P A Todd
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

2.  Renal and neurohumoral effects of ibopamine and metoclopramide in normal man.

Authors:  A R Girbes; D J van Veldhuisen; A J Smit; A Drent-Bremer; S Meijer; W D Reitsma
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.